Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease and SSR1[original query] |
|---|
| The status of EGFR CA SSR1 is a potential prognostic factor for patients with oral squamous cell carcinoma. Oral oncology 2011 Jun 47 (6): 482-6. Lin Yan-Liang, Wang Wen-Yi, Lin Jin-Ching, Wong Yong-Kie, Chien Yi-Ch |
| Genetic variation in the transforming growth factor-ß signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 2011 Sep 117 (18): 4175-83. Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Wolff Roger K, Caan Bette |
| Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov 29 (31): 4113-20. Brugger Wolfram, Triller Nadja, Blasinska-Morawiec Maria, Curescu Stefan, Sakalauskas Raimundas, Manikhas Georgy Moiseevich, Mazieres Julien, Whittom Renaud, Ward Carol, Mayne Karen, Trunzer Kerstin, Cappuzzo Federi |
| Replication Study in a Japanese Population of Six Susceptibility Loci for Type 2 Diabetes Originally Identified by a Transethnic Meta-Analysis of Genome-Wide Association Studies. PloS one 2016 11 (4): e0154093. Matsuba Ren, Imamura Minako, Tanaka Yasushi, Iwata Minoru, Hirose Hiroshi, Kaku Kohei, Maegawa Hiroshi, Watada Hirotaka, Tobe Kazuyuki, Kashiwagi Atsunori, Kawamori Ryuzo, Maeda Shi |
- Page last reviewed:Feb 1, 2024
- Content source:

